Breast MRI: EUSOBI recommendations for women’s information

Ritse M. Mann, Corinne Balleyguier, Pascal A. Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H. Fuchsjäger, Fiona J. Gilbert, Thomas H. Helbich, Sylvia H. Heywang-Köbrunner, Julia Camps-Herrero, Christiane K. Kuhl, Laura Martincich, Federica Pediconi, Pietro Panizza, Luis J. Pina, Ruud M. PijnappelKatja Pinker-Domenig, Per Skaane, Francesco Sardanelli

Research output: Contribution to journalArticle

Abstract

Abstract: This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna–The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI. Key Points: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7–14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation

Original languageEnglish
Pages (from-to)3669-3678
Number of pages10
JournalEuropean Radiology
Volume25
Issue number12
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Breast
Mammary Ultrasonography
Women Physicians
Breast Neoplasms
Phobic Disorders
Menopause
Communication
Kidney
Equipment and Supplies

Keywords

  • Access to information
  • Breast
  • Breast cancer
  • Magnetic resonance imaging
  • Patient advocacy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Mann, R. M., Balleyguier, C., Baltzer, P. A., Bick, U., Colin, C., Cornford, E., ... Sardanelli, F. (2015). Breast MRI: EUSOBI recommendations for women’s information. European Radiology, 25(12), 3669-3678. https://doi.org/10.1007/s00330-015-3807-z

Breast MRI : EUSOBI recommendations for women’s information. / Mann, Ritse M.; Balleyguier, Corinne; Baltzer, Pascal A.; Bick, Ulrich; Colin, Catherine; Cornford, Eleanor; Evans, Andrew; Fallenberg, Eva; Forrai, Gabor; Fuchsjäger, Michael H.; Gilbert, Fiona J.; Helbich, Thomas H.; Heywang-Köbrunner, Sylvia H.; Camps-Herrero, Julia; Kuhl, Christiane K.; Martincich, Laura; Pediconi, Federica; Panizza, Pietro; Pina, Luis J.; Pijnappel, Ruud M.; Pinker-Domenig, Katja; Skaane, Per; Sardanelli, Francesco.

In: European Radiology, Vol. 25, No. 12, 01.12.2015, p. 3669-3678.

Research output: Contribution to journalArticle

Mann, RM, Balleyguier, C, Baltzer, PA, Bick, U, Colin, C, Cornford, E, Evans, A, Fallenberg, E, Forrai, G, Fuchsjäger, MH, Gilbert, FJ, Helbich, TH, Heywang-Köbrunner, SH, Camps-Herrero, J, Kuhl, CK, Martincich, L, Pediconi, F, Panizza, P, Pina, LJ, Pijnappel, RM, Pinker-Domenig, K, Skaane, P & Sardanelli, F 2015, 'Breast MRI: EUSOBI recommendations for women’s information', European Radiology, vol. 25, no. 12, pp. 3669-3678. https://doi.org/10.1007/s00330-015-3807-z
Mann RM, Balleyguier C, Baltzer PA, Bick U, Colin C, Cornford E et al. Breast MRI: EUSOBI recommendations for women’s information. European Radiology. 2015 Dec 1;25(12):3669-3678. https://doi.org/10.1007/s00330-015-3807-z
Mann, Ritse M. ; Balleyguier, Corinne ; Baltzer, Pascal A. ; Bick, Ulrich ; Colin, Catherine ; Cornford, Eleanor ; Evans, Andrew ; Fallenberg, Eva ; Forrai, Gabor ; Fuchsjäger, Michael H. ; Gilbert, Fiona J. ; Helbich, Thomas H. ; Heywang-Köbrunner, Sylvia H. ; Camps-Herrero, Julia ; Kuhl, Christiane K. ; Martincich, Laura ; Pediconi, Federica ; Panizza, Pietro ; Pina, Luis J. ; Pijnappel, Ruud M. ; Pinker-Domenig, Katja ; Skaane, Per ; Sardanelli, Francesco. / Breast MRI : EUSOBI recommendations for women’s information. In: European Radiology. 2015 ; Vol. 25, No. 12. pp. 3669-3678.
@article{c2afc5f41fe1437ea2ece3fa95ea36c6,
title = "Breast MRI: EUSOBI recommendations for women’s information",
abstract = "Abstract: This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS{\circledR} categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna–The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI. Key Points: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7–14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation",
keywords = "Access to information, Breast, Breast cancer, Magnetic resonance imaging, Patient advocacy",
author = "Mann, {Ritse M.} and Corinne Balleyguier and Baltzer, {Pascal A.} and Ulrich Bick and Catherine Colin and Eleanor Cornford and Andrew Evans and Eva Fallenberg and Gabor Forrai and Fuchsj{\"a}ger, {Michael H.} and Gilbert, {Fiona J.} and Helbich, {Thomas H.} and Heywang-K{\"o}brunner, {Sylvia H.} and Julia Camps-Herrero and Kuhl, {Christiane K.} and Laura Martincich and Federica Pediconi and Pietro Panizza and Pina, {Luis J.} and Pijnappel, {Ruud M.} and Katja Pinker-Domenig and Per Skaane and Francesco Sardanelli",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s00330-015-3807-z",
language = "English",
volume = "25",
pages = "3669--3678",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Breast MRI

T2 - EUSOBI recommendations for women’s information

AU - Mann, Ritse M.

AU - Balleyguier, Corinne

AU - Baltzer, Pascal A.

AU - Bick, Ulrich

AU - Colin, Catherine

AU - Cornford, Eleanor

AU - Evans, Andrew

AU - Fallenberg, Eva

AU - Forrai, Gabor

AU - Fuchsjäger, Michael H.

AU - Gilbert, Fiona J.

AU - Helbich, Thomas H.

AU - Heywang-Köbrunner, Sylvia H.

AU - Camps-Herrero, Julia

AU - Kuhl, Christiane K.

AU - Martincich, Laura

AU - Pediconi, Federica

AU - Panizza, Pietro

AU - Pina, Luis J.

AU - Pijnappel, Ruud M.

AU - Pinker-Domenig, Katja

AU - Skaane, Per

AU - Sardanelli, Francesco

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Abstract: This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna–The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI. Key Points: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7–14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation

AB - Abstract: This paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna–The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI. Key Points: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7–14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation

KW - Access to information

KW - Breast

KW - Breast cancer

KW - Magnetic resonance imaging

KW - Patient advocacy

UR - http://www.scopus.com/inward/record.url?scp=84946492061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946492061&partnerID=8YFLogxK

U2 - 10.1007/s00330-015-3807-z

DO - 10.1007/s00330-015-3807-z

M3 - Article

AN - SCOPUS:84946492061

VL - 25

SP - 3669

EP - 3678

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 12

ER -